Francesco Emma Selected Research

Tetanus

1/2021	Evaluation of Immune and Vaccine Competence in Steroid-Sensitive Nephrotic Syndrome Pediatric Patients.
1/2019	Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Emma Research Topics

Disease

34	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2024 - 05/2003
30	Cystinosis 03/2024 - 02/2006
19	Proteinuria 01/2024 - 05/2003
13	Chronic Kidney Failure (Chronic Renal Failure) 11/2021 - 11/2006
10	Renal Insufficiency (Renal Failure) 01/2022 - 06/2003
8	Fanconi Syndrome (Syndrome, Fanconi) 01/2020 - 09/2013
6	Hypertension (High Blood Pressure) 01/2024 - 08/2005
5	Kidney Diseases (Kidney Disease) 01/2023 - 01/2021
5	Rare Diseases (Rare Disease) 12/2021 - 01/2012
5	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2020 - 05/2003
5	Infections 10/2019 - 06/2009
4	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2024 - 03/2015
4	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 12/2021 - 01/2019
4	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020 - 01/2016
3	IGA Glomerulonephritis (IGA Nephropathy) 11/2023 - 03/2005
3	Acidosis 12/2021 - 07/2014
3	Donnai-Barrow syndrome 08/2021 - 01/2020
3	Atypical Hemolytic Uremic Syndrome 02/2021 - 12/2013
3	Cystinuria 01/2021 - 01/2010
3	Chronic Renal Insufficiency 12/2020 - 03/2016
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 03/2006
3	Autosomal Dominant Polycystic Kidney (ADPKD) 11/2019 - 03/2016
3	Disease Progression 07/2019 - 05/2007
2	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 01/2024 - 01/2023
2	Glomerulonephritis 12/2023 - 12/2019
2	Hyperparathyroidism 11/2022 - 01/2019
2	Bartter Syndrome (Syndrome, Bartter) 11/2022 - 01/2021
2	Coenzyme Q10 Deficiency 01/2022 - 01/2022
2	Inborn Genetic Diseases (Disease, Hereditary) 12/2021 - 07/2019
2	Alkalosis 01/2021 - 03/2006
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 11/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2015
2	Tetanus 01/2021 - 01/2019
2	Segmental glomerulosclerosis 01/2020 - 01/2006
2	Cysts 07/2019 - 03/2016
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 03/2016 - 03/2012
2	Hereditary Nephritis (Alport Syndrome) 05/2013 - 07/2010
2	Dent Disease 10/2009 - 09/2006
1	Hematuria 01/2024
1	Polyuria 01/2024

Drug/Important Bio-Agent (IBA)

24	Cystine (L-Cystine)IBA 01/2024 - 05/2008
15	SteroidsIBA 01/2024 - 05/2003
10	Cysteamine (Mercaptamine)FDA Link 01/2023 - 11/2010
9	Rituximab (Mabthera)FDA Link 01/2024 - 04/2014
7	Prednisone (Sone)FDA LinkGeneric 01/2024 - 01/2017
7	SymportersIBA 11/2021 - 08/2012
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2007
6	AntibodiesIBA 10/2021 - 12/2013
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2024 - 09/2004
5	Phosphates (Orthophosphate)IBA 01/2024 - 01/2016
5	Complement System Proteins (Complement)IBA 12/2023 - 12/2013
5	Protons (Proton)IBA 12/2021 - 09/2014
5	SaltsIBA 01/2021 - 09/2005
5	NPHS2 proteinIBA 07/2013 - 05/2003
4	Monoclonal AntibodiesIBA 01/2024 - 01/2017
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2017
3	GlucocorticoidsIBA 01/2023 - 05/2008
3	CalciumIBA 11/2022 - 01/2012
3	dirhodium tetraacetate (DRTA)IBA 12/2021 - 01/2019
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2021 - 03/2005
3	ofatumumab FDA Link 10/2021 - 01/2017
3	Low Density Lipoprotein Receptor-Related Protein-2IBA 08/2021 - 01/2020
3	Immunoglobulin G (IgG)IBA 01/2021 - 03/2015
3	Mitochondrial DNA (mtDNA)IBA 01/2020 - 03/2006
3	Protein Isoforms (Isoforms)IBA 01/2017 - 09/2006
2	Semaphorins (Semaphorin)IBA 01/2024 - 11/2020
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2024 - 11/2020
2	Messenger RNA (mRNA)IBA 01/2024 - 08/2011
2	burosumabIBA 01/2024 - 01/2022
2	Amino Acids FDA Link 09/2022 - 10/2009
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	coenzyme Q10 (CoQ10)IBA 01/2022 - 05/2016
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2020
2	ubiquinone 6IBA 01/2022 - 01/2022
2	Calcineurin InhibitorsIBA 10/2021 - 10/2017
2	LigandsIBA 08/2021 - 01/2020
2	eculizumab FDA Link 02/2021 - 03/2012
2	AntigensIBA 01/2021 - 12/2019
2	AlkaliesIBA 01/2021 - 01/2010
2	TinIBA 01/2021 - 11/2006
2	Immunoglobulin M (IgM)IBA 01/2021 - 10/2019
2	Neprilysin (Neutral Endopeptidase)IBA 12/2019 - 03/2015
2	Tolvaptan FDA Link 07/2019 - 03/2016
2	Levamisole (Decaris)FDA Link 01/2019 - 01/2018
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 03/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018 - 09/2009
2	ElectrolytesIBA 04/2017 - 07/2014
2	ThrombomodulinIBA 09/2016 - 12/2013
2	CopperIBA 01/2016 - 09/2013
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2005 - 03/2005
1	Vitamin D FDA LinkGeneric 01/2024
1	AntiportersIBA 01/2024
1	obinutuzumabIBA 01/2024
1	Fibroblast Growth Factor-23IBA 01/2024
1	Interleukin-6 (Interleukin 6)IBA 01/2024

Therapy/Procedure

18	Therapeutics 01/2024 - 01/2006
5	Kidney Transplantation 01/2015 - 06/2003
2	Transplantation 01/2020 - 05/2007
2	Renal Dialysis (Hemodialysis) 05/2015 - 09/2013
1	Transition to Adult Care 03/2024